Navigation Links
Dialysis Corporation of America Announces First Quarter 2008 Earnings Release Date
Date:4/25/2008

LINTHICUM, Md., April 25 /PRNewswire-FirstCall/ -- Dialysis Corporation of America (Nasdaq: DCAI) announced today that it will release its first quarter 2008 financial results on May 7, 2008, after the close of the market. The company will also host a conference call in conjunction with its first quarter 2008 earnings release the following morning, May 8, 2008 at 10:00 AM EDT.

Those interested in participating in the May 8, 2008 conference call may dial in at 1-800-260-6066 using pass code 7002477, or through simulcast on the internet at http://www.investorcalendar.com/IC/CEPage.asp?ID=128467 . Participants may be asked to provide the title of the conference call, which is "Dialysis Corporation of America 1st Quarter Earnings." The conference call will be available for replay on the company's website http://www.dialysiscorporation.com for a period of thirty days following the call.

Dialysis Corporation of America currently owns 35 free standing kidney hemodialysis centers in Pennsylvania, New Jersey, Georgia, Ohio, Maryland, Virginia and South Carolina providing patients with a full range of quality in-center and at-home hemodialysis services, as well as providing in-hospital services in many of the company's markets.

This release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to delays beyond the company's control with respect to future business events, regulation of dialysis operations, determination of reimbursement rates by Medicare and private payers, and other risks detailed in the company's filings with the SEC, particularly as described in the company's annual report on Form 10-K for the fiscal year ended December 31, 2007.

The company's press releases, corporate profile, corporate governance materials, quarterly and current reports, and other filings with the SEC are available on Dialysis Corporation of America's internet home page: http://www.dialysiscorporation.com .


'/>"/>
SOURCE Dialysis Corporation of America
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
2. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
3. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
4. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance
5. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
6. LifeCell Corporation Schedules First Quarter 2008 Financial Results Conference Call; April 24, 2008 at 10:00 A.M. Eastern
7. eBioscience Corporation Announced Today That James Glynn Has Been Appointed to Its Board of Directors, Effective April 15, 2008
8. Sumitomo Corporation of America Named Exclusive Distribution and Sales Agent for Chiral Quest
9. IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference
10. Sigma-Aldrich Corporation 1st Quarter 2008 Earnings Conference Call
11. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... Cancer experts from Austria, Hungary, Switzerland, ... a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just ... now. , Biomarkers are components in the blood, tissue or body fluids ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
(Date:3/18/2016)... LONDON , March 18, 2016 ... Established Suppliers of Biometrics, ICT, Manned & Unmanned Vehicles, Physical ... & security companies in the border security market and ... and Europe has led ... your companies improved success. --> defence & ...
Breaking Biology News(10 mins):